Dergiler / Kocatepe Tıp Dergisi / 2018 / Cilt: 19 - Sayı: 4

ZOR ASTIM

SEVERE ASTHMA

Sayfa
157–163
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Astım havayolu inflamasyonu ile seyreden çeşitli klinik

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Astım havayolu inflamasyonu ile seyreden çeşitli klinik
📊
Temel Bulgular & Veri:Astım havayolu inflamasyonu ile seyreden çeşitli klinik
💡
Sonuç & Katkı:Astım havayolu inflamasyonu ile seyreden çeşitli klinik
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Astım fenotipleri · astım kontrolü · kortikosteroid

Özet

Astım havayolu inflamasyonu ile seyreden çeşitli klinik

Abstract

Asthma is a common inflammatory disease that has wideclinical characteristics of the airway of the lungs. Asthmasymptoms can be prevented by avoiding triggers likeallergens and by the effective inhaled treatment. Themajority of asthma patients can be treated effectivelyby current medications. Difficult asthma is a distinctentity of asthma, comprising approximately %5-10 ofasthmatic patients. Despite the high effective treatment,the patients with asthma have disease that is poorlycontrolled. Severe asthmatics account for up to half ofthe cost for asthma. It will include asthma uncontrolledby new standard therapy, steroid dependent, steroidresistant asthma patients. Asthma related deathsare seen especially in severe asthma group. Asthmais a heterogeneous disease, consisting of differentphenotypes. It requires multidisciplinary approach fortreatment management. Severe asthma may suddenlydevelop in early time in disease or overtime. There was anevidence that severe asthma related to genetic factors,environmental factors, age, inflammation, duration ofdisease The genetic and environmental factors mayplay a role in severe asthma management. Phenotypetargetedtherapy has an important role in severe asthma,but it is associated with high treatment costs. At firstdiagnosis of asthma must be confirmed COPD and vocalcord dysfunction is needed to be particular interest indifferential diagnosis. Triggering factors such as smoking,atopy, work place condition and aspirin hypersensitivityshould be evaluated. Comorbidities that may affectasthma should be considered. This review examinesthe definition of asthma, its differential diagnosis,phenotypes and available treatment options.

🔖

Bu Makaleye Atıf Yap

SAĞMEN, S. B., CEYHAN, B. (2018). ZOR ASTIM. Kocatepe Tıp Dergisi, Cilt: 19 - Sayı: 4, 157–163. https://ajindex.com/articles/201206

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Revised 2017 available from
  2. Bavbek S, Misirligil Z; Study Group. A breath for health: an exploratory study in severe asthma patients in Turkey. Allergy 2008;63(9): 1218-27
  3. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43(2):343-73
  4. Bousquet J, Jeffery PK, Busse WW, et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45
  5. Miller AL, Lukacs NW. Chemokine receptors: understanding their role in asthmatic disease. Immunol Allergy Clin North Am 2004;24:667-83, vii
  6. Simpson JL, Scott RJ, Boyle MJ, et al. Differential proteolytic enzyme activity in eosinophillic and neutrophillic asthma. Am J Respir Crit Care Med 2005;172:559-65
  7. Hastie AT, Moore WC, Meyers DA, et al. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 2010; 125: 1028–1036 8. Kharitonov SA. Exhaled nitric oxide and carbon monoxide in asthma. Eur Respir Rev 1999;68:212-18
  8. Turktas H, Oguzulgen K, Kokturk N, et al. Correlation of exhaled nitric oxide levels and airway inflammation markers in stable asthmatic patients. J Asthma 2003;40:425-30
  9. Vignola AM, Mirabella F, Costanzo G, et al. Airway remodeling in asthma. Chest 2003;123(3 Suppl):417S-22S 11. Robinson DS, Campbell DA, Durham SR, et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003; 22: 478–483
  10. Aaron SD, Vandemheen KL, Boulet LP, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008; 179: 1121–1131
  11. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:405–413
  12. The ENFUMOSA cross-sectional Europe an multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003;22(3):470-7
  13. Ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002; 109: 621–626
  14. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation i